Blockade of the neurohormonal systems in heart failure with preserved ejection fraction. A contemporary meta-analysis
Background: Although individual studies failed to demonstrate significant benefits with neurohormonal inhibitors in patients affected by heart failure (HF) with preserved ejection fraction (HFpEF), an evident trend towards a reduction in hospitalization and mortality has been previously documented in most cases.